Loading clinical trials...
Loading clinical trials...
Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination As Adjunctive Therapy to Travoprost
Conditions
Interventions
Brinzolamide 1%/brimonidine 0.2% ophthalmic suspension
Vehicle
+1 more
Start Date
October 1, 2013
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
May 14, 2015
NCT07396441
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
Lead Sponsor
Alcon Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions